Page last updated: 2024-10-29

ketanserin and Benign Neoplasms, Brain

ketanserin has been researched along with Benign Neoplasms, Brain in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felding, M1
Cold, GE1
Jacobsen, CJ1
Stjernholm, P1
Voss, K1
Elliott, JM1
Newberry, NR1
Cholewinski, AJ1
Bartrup, JT1
Briddon, SJ1
Carey, JE1
Flanigan, TP1
Newton, RA1
Phipps, SL1
Reavley, AC1

Other Studies

2 other studies available for ketanserin and Benign Neoplasms, Brain

ArticleYear
The effect of ketanserin upon postoperative blood pressure, cerebral blood flow and oxygen metabolism in patients subjected to craniotomy for cerebral tumours.
    Acta anaesthesiologica Scandinavica, 1995, Volume: 39, Issue:5

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Temperature; Brain; Brain Neoplasms; Cere

1995
Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells.
    Neuroscience, 1995, Volume: 69, Issue:4

    Topics: Animals; Brain Neoplasms; Calcium; Cell Line; Dose-Response Relationship, Drug; Glioma; Ketanserin;

1995